deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT03342456

The Efficacy and Safety of Ilaprazole/Doxycycline-based Bismuth-containing Quadruple Therapy on Hp Infected Duodenal Ulcers

The Efficacy and Safety of Ilaprazole/Doxycycline-based Bismuth-containing Quadruple Therapy on Hp Infected Duodenal Ulcers: A Randomized, Parallel-controlled Multi-center Study

Sponsor: Livzon Pharmaceutical Group Inc.

Conditions Duodenal Ulcer Due to Helicobacter Pylori
Interventions Amoxicillin Capsules Doxycycline Hyclate Enteric-Coated Capsules Furazolidone Tablets Ilaprazole Enteric-Coated Tablets Potassium Citrate Tablets
Updated 10 times since 2017 Last updated: Feb 26, 2022 Started: Dec 13, 2017 Primary completion: Jun 20, 2019 Completion: Sep 20, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Duodenal Ulcer Due to Helicobacter Pylori and is currently completed. Livzon Pharmaceutical Group Inc. leads this study, which shows 10 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Dec 2017 – ~Jun 2018 · 6 months · monthly snapshotNot Yet Recruiting~Jun 2018 – ~Nov 2018 · 5 months · monthly snapshotRecruiting~Nov 2018 – ~Aug 2019 · 9 months · monthly snapshotRecruiting~Aug 2019 – ~Jul 2020 · 11 months · monthly snapshotRecruiting~Jul 2020 – ~Jan 2021 · 6 months · monthly snapshotCompleted~Jan 2021 – ~Mar 2022 · 14 months · monthly snapshotCompleted~Mar 2022 – ~Apr 2022 · 31 days · monthly snapshotCompleted~Apr 2022 – ~Jul 2024 · 27 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 23 months · monthly snapshotCompleted

Change History

10 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Apr 2022 — Jul 2024 [monthly]

    Completed PHASE4

  4. Mar 2022 — Apr 2022 [monthly]

    Completed PHASE4

  5. Jan 2021 — Mar 2022 [monthly]

    Completed PHASE4

▶ Show 5 earlier versions

  1. Jul 2020 — Jan 2021 [monthly]

    Completed PHASE4

    Status: Recruiting → Completed

  2. Aug 2019 — Jul 2020 [monthly]

    Recruiting PHASE4

  3. Nov 2018 — Aug 2019 [monthly]

    Recruiting PHASE4

  4. Jun 2018 — Nov 2018 [monthly]

    Recruiting PHASE4

    Status: Not Yet Recruiting → Recruiting

  5. Dec 2017 — Jun 2018 [monthly]

    Not Yet Recruiting PHASE4

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Livzon Pharmaceutical Group Inc.
  • The Third Xiangya Hospital of Central South University
  • Yung Shin Pharm. Ind. Co., Ltd.
Data source: The Third Xiangya Hospital of Central South University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations